Market Tracker

11/27 6:05pm ET

Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

13.21
Data as of Nov 26
 +0.455 / +3.57%
Today’s Change
2.45
Today|||52-Week Range
15.00
+298.01%
Year-to-Date

Today’s Trading

Previous close12.76
Today’s open12.75
Day’s range12.63 - 13.30
Volume3,225,951
Average volume (3 months)6,554,131
Market cap$1.3B
Dividend yield--
Data as of 4:00pm ET, 11/26/2014

Growth & Valuation

Earnings growth (last year)+1.56%
Earnings growth (this year)-5.54%
Earnings growth (next 5 years)+5.23%
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book8.36

Competitors

 Today’s
change
Today’s
% change
USNAUSANA Health Science...-1.34-1.25%
PDLIPDL BioPharma Inc-0.10-1.27%
TSROTESARO Inc+0.84+2.48%
INSYInsys Therapeutics I...+1.19+3.06%
Data as of 4:02pm ET, 11/26/2014

Financials

Next reporting dateMarch 4, 2015
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$0.00
Annual profit (last year)-$58.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Milind S. Deshpande
CFO, Secretary, EVP &
Investor Relations Contact
Mary Kay Fenton
Corporate headquarters
New Haven, Connecticut

Forecasts